ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.
about
Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse modelsA small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft modelDissecting the expression landscape of RNA-binding proteins in human cancersStructures of the Ets Protein DNA-binding Domains of Transcription Factors Etv1, Etv4, Etv5, and Fev: DETERMINANTS OF DNA BINDING AND REDOX REGULATION BY DISULFIDE BOND FORMATION.Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5.The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancerThe Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate Cancer.Mouse models of prostate cancer: picking the best model for the question.Histone H2A.Z deregulation in prostate cancer. Cause or effect?A small molecule that binds and inhibits the ETV1 transcription factor oncoproteinNovel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer.Molecular pathways and targets in prostate cancerA Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland.The ETS family of oncogenic transcription factors in solid tumours.The Molecular Taxonomy of Primary Prostate Cancer.Osteopontin-c mediates the upregulation of androgen responsive genes in LNCaP cells through PI3K/Akt and androgen receptor signaling.Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motilitySpecific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contextsHistone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India.ETS transcription factor ERG cooperates with histone demethylase KDM4A.ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer.Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and CaucasiansMaintaining and reprogramming genomic androgen receptor activity in prostate cancer.Detailed longitudinal sampling of glioma stem cells in situ reveals Chr7 gain and Chr10 loss as repeated events in primary tumor formation and recurrence.ERG expression in prostate cancer: biological relevance and clinical implication.ETV4 and AP1 Transcription Factors Form Multivalent Interactions with three Sites on the MED25 Activator-Interacting Domain.c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks.Discovery Proteomics Identifies a Molecular Link between the Coatomer Protein Complex I and Androgen Receptor-dependent TranscriptionThe Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer Biomarker.Reduced Erg Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells.Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancerSuppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation.Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models.Novel Gemini vitamin D3 analogs: large structure/function analysis and ability to induce antimicrobial peptide.Rationale for the development of alternative forms of androgen deprivation therapy.Deletion of Interstitial Genes between TMPRSS2 and ERG Promotes Prostate Cancer Progression.Upregulation of PSMD10 caused by the JMJD2A histone demethylase.
P2860
Q27311359-423FF30E-2CAD-46F7-A98A-FFF5A84D0FEBQ27322372-4581880B-A43E-43DD-8AFC-608B5F950C42Q28305624-4009F921-DE03-4EC2-9649-A615222AF15EQ30373611-845E12B1-D3F8-48F3-B8DA-40991B766115Q33558203-525F70C1-4CA4-494C-B75D-BB1E4CA28236Q33698635-71799696-3463-47C6-A05F-5FCBAF8D2068Q33702987-862635BD-02C0-400B-AB08-4D99F91590D0Q33940867-39FD579A-ECC4-421F-9BC3-337F1422119CQ33962848-EA48C8BE-81F9-4E1C-8AD6-7B412BF4595AQ34132931-2AE60477-1479-48F8-AB0E-CEAFF01953C6Q34158217-EA8ADA5F-A9F0-4F6E-B13F-B58689C5E1ECQ34365632-6304AC57-DA88-4552-A31E-0860B2BC3FA6Q34550256-B4D91AAE-E59D-4914-8E15-9BEE766F0F26Q34555986-734AB3A0-D78B-4829-9B72-B1523EFF4BDFQ34674332-9D644586-4216-4D43-8E9F-CC0A44B68091Q35167752-98374991-298D-40C2-8293-0AB1CC591EC0Q35554127-B83D8CDA-82A0-44BB-8FE9-4950E7BAFEF7Q35605311-4F6F9243-B498-4C3A-B404-D2F07EFDC346Q35741647-46B2BF2C-B6F2-4C53-9937-D4789379E6ABQ36515134-C7FA0750-6123-40A2-A009-E664EC59DF68Q36800086-5A61D5EE-A9E9-4375-8DA7-EA43BAB0519BQ36908878-4E056787-9C1F-4CCB-868B-CCCFC1927E7DQ37173209-1503DCA6-6DB7-4BFC-BF73-4A6FBB7A92BBQ37702713-5DC9B75B-84D1-41A3-9EC5-F12E315A1443Q38190362-F26EEF89-21E6-4A1B-A2AA-CCDD2DCA0965Q38677899-EF371091-A35C-4B08-A08F-F7ECE747E790Q38681610-DFA3DF16-8D0B-4B5E-937E-0D35EE732177Q38696706-987D1951-32BB-4691-8004-F5D3C5F94D22Q38707571-48481DD9-70C8-4E8E-B160-D5D545A5179EQ38760518-2A4363DA-8DD9-42CD-8755-E0B451F8B62EQ38766041-0492264B-76B8-45EB-A037-12C33868B37EQ38823486-2BB84A6C-76C3-4FE3-AFAF-38324AED4B84Q38900181-E946715F-6E6C-4E04-A976-2401D322F3C4Q38912800-5D401914-F382-42C5-A741-3B7AAA0CE4FDQ38952586-C4B395B6-C672-4443-8D2B-CF86CAF709ECQ38977467-410CDA6C-DDD5-40E4-866C-430777BCF68AQ39138273-C3316F28-52A4-49CF-BB96-FFC46615D688Q39342369-748BF75A-ECDC-4E49-911E-8D7F57C32AF3Q40908009-A9CE0876-96DD-47E8-82C8-87696A068972Q41615123-F4791733-2330-471B-B1ED-5E744D153321
P2860
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
ETV1 directs androgen metaboli ...... in targeted mice and patients.
@en
ETV1 directs androgen metaboli ...... in targeted mice and patients.
@nl
type
label
ETV1 directs androgen metaboli ...... in targeted mice and patients.
@en
ETV1 directs androgen metaboli ...... in targeted mice and patients.
@nl
prefLabel
ETV1 directs androgen metaboli ...... in targeted mice and patients.
@en
ETV1 directs androgen metaboli ...... in targeted mice and patients.
@nl
P2093
P2860
P50
P356
P1433
P1476
ETV1 directs androgen metaboli ...... in targeted mice and patients.
@en
P2093
Douglas E Linn
Esther Baena
Frank J Godinho
Guo-Cheng Yuan
Jonghwan Kim
Melanie J Hamblen
Minh Nguyen
Roderick T Bronson
Stuart H Orkin
P2860
P304
P356
10.1101/GAD.211011.112
P577
2013-03-01T00:00:00Z